Contineum Therapeutics, Inc. · NASDAQ:CTNM
Franklin Resources Inc reported a 8.90% stake in Contineum Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 5, 2025
Franklin Resources Inc reported a 8.90% stake in Contineum Therapeutics, Inc., 1,698,825 shares, as a passive investor on Jun 30, 2025. Filed Aug 5, 2025 (Schedule 13G/A).
- Stake
- 8.90%
- Shares
- 1,698,825
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Franklin Resources, Inc. | 8.90% | 1,698,825 |
| Charles B. Johnson | 0% | 0 |
| Rupert H. Johnson, Jr. | 0% | 0 |
| Franklin Advisers, Inc. | 8.90% | 1,698,825 |
Source
Related
- Contineum Therapeutics, Inc.
- Franklin Resources Inc
- Contineum Therapeutics, Inc. shareholders
- Schedule 13G/A · Franklin Resources Inc · Jan 29, 2026
- Schedule 13G/A · Franklin Resources Inc · Nov 4, 2025
- Schedule 13G · Trails Edge Capital Partners, LP · Oct 22, 2026
- Form 4 · Stengone Carmine N. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Form 4 · Stengone Carmine N. · Aug 3, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026